Danaparoid and hepatic function abnormal Patient Reports February 12, 2012

Danaparoid Side Effects Report #5046810-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, hepatic function abnormal, pneumonia , renal impairment, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5113496-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, shock haemorrhagic, wound infection. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, CEFAZOLIN, AMIKACIN SULPHATE, SACCHARATED IRON OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5027830-X
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation, open fracture, iron deficiency anaemia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, hepatic function abnormal, wound infection. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, CEFAZOLIN, AMIKACIN SULPHATE, SACCARATED IRON OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5113491-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, blood lactate dehydrogenase increased, condition aggravated, hepatic function abnormal, malnutrition, platelet count decreased, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5030651-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, hepatic function abnormal, malnutrition, postoperative infection, renal impairment, wound haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5121583-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Male patient, 69 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematoma, haemorrhagic diathesis, henoch-schonlein purpura, hepatic function abnormal, renal disorder, staphylococcal infection . Danaparoid dosage: unknown. During the same period patient was treated with ENOXAPARIN, DEXPANTHENOL, ALPROSTADIL, MEROPENEM, MINOPHAGEN C, VANCOMYCIN, HEPARIN, WARFARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5124726-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5024837-3
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on June 01, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, sepsis , septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5153401-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 57 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, hepatic function abnormal, multi-organ failure, neoplasm malignant, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, NAFAMOSTAT MESILATE, DOPAMINE, OMEPRAZOLE, CEFOZOPRAN HYDROCHLORIDE, ANTITHROMBIN III, ULINASTATIN. Patient died.


Danaparoid Side Effects Report #5153402-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Female patient, 49 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, MINOCYCLINE, CILASTATIN W, OMEPRAZOLE, NAFAMOSTAT MESILATE, SIVELESTAT, DOPAMINE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5123364-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, platelet count increased, protein total decreased, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5030494-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, renal impairment, sepsis , thermal burn. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5116965-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, CILASTATIN W, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5115458-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 13, 2006. Male patient, 17 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, condition aggravated, hepatic function abnormal. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFPIROME SULPHATE, ANTITHROMBIN III, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ULINASTATIN, OMEPRAZOLE, GABEXATE MESILATE. Patient died.


Danaparoid Side Effects Report #5116967-2
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 19, 2006. Male patient, 74 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, condition aggravated, disseminated intravascular coagulation, haematuria, hepatic function abnormal, malnutrition, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE, TEICOPLANIN. Patient was hospitalized. Patient recovered.